DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS

DCR 请求 Leidos BIOMEDICAL RESEARCH, INC. 提供服务来启动管理、监督、执行、结束和发布调查结果

• 批准号: 10280923
• 负责人: ETHAN DMITROVSKY
• 金额: $ 112.58万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-28 至 2025-09-27
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10280923
• 关键词: Biomedical Research; Case Management; Characteristics; Clinical; Clinical Research; Communicable Diseases; Diagnostic tests; Disease; Disease Outbreaks; Epidemiology; Etiology; Future; Indonesia; Infection; Lead; Outcome; Outcomes Research; Process; Protocols documentation; Public Health; Publications; Reporting; Research; Sampling; Services; disorder control; disorder prevention; epidemiologic data; experience; improved; operation; pandemic disease; research study

Containing outbreaks that might lead to pandemics is a crucial public health operation that is strengthened by clinical research studies on the etiologies, epidemiology, clinical manifestations, and case management processes of infectious diseases. The INA-RESPOND Network maintains an extensive and experienced research presence across Indonesia that is capable of conducting research on ongoing infectious disease outbreaks and difficult cases of unidentified etiology. This 5-year protocol will leverage the unique capacity of the INA-RESPOND Network to rapidly study sudden disease outbreaks, difficult infectious disease cases of unidentified etiology, and samples collected during historical outbreaks and cases of unknown etiologies. The outcomes of this research will significantly improve our understanding of circulating diseases in Indonesia, particularly those that are most challenging to identify and of greatest outbreak concern.

控制可能导致大流行的疫情是一项至关重要的公共卫生行动，通过对传染病的病因学、流行病学、临床表现和病例管理过程进行临床研究，加强了这一行动。INA-RESPOND网络在印度尼西亚各地保持着广泛和经验丰富的研究存在，能够对正在发生的传染病爆发和病因不明的疑难病例进行研究。这项为期5年的协议将利用INA-RESPOND网络的独特能力，快速研究突发疾病爆发、病因不明的疑难传染病病例以及在历史爆发和病因不明病例期间收集的样本。这项研究的结果将大大提高我们对印度尼西亚流行病的理解，特别是那些最难识别和最大爆发问题的疾病。